Preoperative CECT-Based Multitask Model Predicts Peritoneal Recurrence and Disease-Free Survival in Advanced Ovarian Cancer: A Multicenter Study.
Acad Radiol
; 2024 Apr 30.
Article
in En
| MEDLINE
| ID: mdl-38693025
ABSTRACT
RATIONALE AND OBJECTIVES:
Peritoneal recurrence is the predominant pattern of recurrence in advanced ovarian cancer (AOC) and portends a dismal prognosis. Accurate prediction of peritoneal recurrence and disease-free survival (DFS) is crucial to identify patients who might benefit from intensive treatment. We aimed to develop a predictive model for peritoneal recurrence and prognosis in AOC.METHODS:
In this retrospective multi-institution study of 515 patients, an end-to-end multi-task convolutional neural network (MCNN) comprising a segmentation convolutional neural network (CNN) and a classification CNN was developed and tested using preoperative CT images, and MCNN-score was generated to indicate the peritoneal recurrence and DFS status in patients with AOC. We evaluated the accuracy of the model for automatic segmentation and predict prognosis.RESULTS:
The MCNN achieved promising segmentation performances with a mean Dice coefficient of 84.3% (range 78.8%-87.0%). The MCNN was able to predict peritoneal recurrence in the training (AUC 0.87; 95% CI 0.82-0.90), internal test (0.88; 0.85-0.92), and external test set (0.82; 0.78-0.86). Similarly, MCNN demonstrated consistently high accuracy in predicting recurrence, with an AUC of 0.85; 95% CI 0.82-0.88, 0.83; 95% CI 0.80-0.86, and 0.85; 95% CI 0.83-0.88. For patients with a high MCNN-score of recurrence, it was associated with poorer DFS with P < 0.0001 and hazard ratios of 0.1964 (95% CI 0.1439-0.2680), 0.3249 (95% CI 0.1896-0.5565), and 0.3458 (95% CI 0.2582-0.4632).CONCLUSION:
The MCNN approach demonstrated high performance in predicting peritoneal recurrence and DFS in patients with AOC.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acad Radiol
Journal subject:
RADIOLOGIA
Year:
2024
Document type:
Article